EMC Reiterated at Buy and 3 Analyst-Reiterated Ratings to See Now

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on October 1st.

EMC (NYSE:EMC): Cantor Fitzgerald reiterated its rating of Buy for this company and changed its price target from $30 to $31.

Endo Pharm (NASDAQ:ENDP): Cantor Fitzgerald reiterated its rating of Hold for this company and changed its price target from $37 to $31.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Home Bancshares (NASDAQ:HOMB): Wunderlich reiterated its rating of Buy for this company and changed its price target from $35 to $37.

First Cash (NASDAQ:FCFS): FBR Capital reiterated its rating of Outperform for this company and changed its price target from $48 to $52.

Don’t Miss: 3 Major Gaming Players Feel the Heat from This Unexpected New Enemy.